Loading...
  • Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016
    Capital Cube7 days ago

    Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016

    Click here to see latest analysisAcasti Pharma, Inc. reports financial results for the quarter ended May 31, 2016.HighlightsSummary numbers: Revenues of USD 0.00 million, Net Earnings of USD -2.42 million.Gross margins narrowed from -11,357.12% to -20,974.65% compared to the same period last year, operating (EBITDA) margins now -82,173.61% from -39,469.07%.Change in operating cash flow of […] (Read more...) The post Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q1, 2017 By the Numbers : July 22, 2016 appeared first on CapitalCube.

  • Associated Press18 days ago

    Acasti reports 1Q loss

    The Laval, Quebec-based company said it had a loss of 23 cents per share. The biopharmaceutical company posted revenue of $2,000 in the period. In the final minutes of trading on Monday, the company's ...